-
-
-
-
-
-
-
Monte Rosa Therapeutics (GLUE) PT Lowered to $30 at Jefferies
-
-
-
-
-
-
-
Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026
-
-
-
-
-
-
-
Monte Rosa presents preclinical data on MRT-6160 for autoimmune diseases
-
-
-
-
-
-
-
Monte Rosa Therapeutics (GLUE) Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat H
-
-
-
-
-
-
-
Monte Rosa Therapeutics, Inc. (GLUE) Tops Q3 EPS by 18c
-
-
-
-
-
-
-
Monte Rosa Therapeutics, Inc. (GLUE) Tops Q2 EPS by 10c
-
-
-
-
-
456,369 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

